Miao Chang1,2,3, Fay Y Womer4, E Kale Edmiston3, Chuan Bai1,3, Qian Zhou2,3, Xiaowei Jiang1,3, Shengnan Wei1,3, Yange Wei2,3, Yuting Ye5, Haiyan Huang5, Yong He6, Ke Xu1,3, Yanqing Tang2,3, Fei Wang1,2,3. 1. Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, PR China. 2. Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, PR China. 3. Brain Function Research Section, The First Affiliated Hospital of China Medical University, Shenyang, PR China. 4. Department of Psychiatry, Washington University School of Medicine, St Louis, MO. 5. Division of Biostatistics, University of California, Berkeley, Berkeley, CA. 6. State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, PR China.
Abstract
BACKGROUND: Schizophrenia (SZ), bipolar disorder (BD), and major depressive disorder (MDD) are distinct diagnostic categories in current psychiatric nosology, yet there is increasing evidence for shared clinical and biological features in these disorders. No previous studies have examined brain structural features concurrently in these 3 disorders. The aim of this study was to identify the extent of shared and distinct brain alterations in SZ, BD, and MDD. We examined gray matter (GM) volume and white matter (WM) integrity in a total of 485 individuals (135 with SZ, 86 with BD, 108 with MDD, and 156 healthy controls [HC]) who underwent high-resolution structural magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) at a single site. RESULTS: Significant 4-group (SZ, BD, MDD, and HC groups) differences (P < .05, corrected) in GM volumes were found primarily in the paralimbic and heteromodal corticies. Post hoc analyses showed that the SZ, BD, and MDD groups shared GM volume decreases in 87.9% of the total regional volume with significant 4-group differences. Significant 4-group differences in WM integrity (P < .05 corrected) were found in callosal, limbic-paralimbic-hetermodal, cortico-cortical, thalamocortical and cerebellar WM. Post hoc analyses revealed that the SZ and BD groups shared WM alterations in all regions, while WM alterations were not observed with MDD. CONCLUSIONS: Our findings of common alterations in SZ, BD, and MDD support the presence of core neurobiological disruptions in these disorders and suggest that neural structural distinctions between these disorders may be less prominent than initially postulated, particularly between SZ and BD.
BACKGROUND:Schizophrenia (SZ), bipolar disorder (BD), and major depressive disorder (MDD) are distinct diagnostic categories in current psychiatric nosology, yet there is increasing evidence for shared clinical and biological features in these disorders. No previous studies have examined brain structural features concurrently in these 3 disorders. The aim of this study was to identify the extent of shared and distinct brain alterations in SZ, BD, and MDD. We examined gray matter (GM) volume and white matter (WM) integrity in a total of 485 individuals (135 with SZ, 86 with BD, 108 with MDD, and 156 healthy controls [HC]) who underwent high-resolution structural magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) at a single site. RESULTS: Significant 4-group (SZ, BD, MDD, and HC groups) differences (P < .05, corrected) in GM volumes were found primarily in the paralimbic and heteromodal corticies. Post hoc analyses showed that the SZ, BD, and MDD groups shared GM volume decreases in 87.9% of the total regional volume with significant 4-group differences. Significant 4-group differences in WM integrity (P < .05 corrected) were found in callosal, limbic-paralimbic-hetermodal, cortico-cortical, thalamocortical and cerebellar WM. Post hoc analyses revealed that the SZ and BD groups shared WM alterations in all regions, while WM alterations were not observed with MDD. CONCLUSIONS: Our findings of common alterations in SZ, BD, and MDD support the presence of core neurobiological disruptions in these disorders and suggest that neural structural distinctions between these disorders may be less prominent than initially postulated, particularly between SZ and BD.
Authors: Madeleine Goodkind; Simon B Eickhoff; Desmond J Oathes; Ying Jiang; Andrew Chang; Laura B Jones-Hagata; Brissa N Ortega; Yevgeniya V Zaiko; Erika L Roach; Mayuresh S Korgaonkar; Stuart M Grieve; Isaac Galatzer-Levy; Peter T Fox; Amit Etkin Journal: JAMA Psychiatry Date: 2015-04 Impact factor: 21.596
Authors: Tilo Kircher; Markus Wöhr; Igor Nenadic; Rainer Schwarting; Gerhard Schratt; Judith Alferink; Carsten Culmsee; Holger Garn; Tim Hahn; Bertram Müller-Myhsok; Astrid Dempfle; Maik Hahmann; Andreas Jansen; Petra Pfefferle; Harald Renz; Marcella Rietschel; Stephanie H Witt; Markus Nöthen; Axel Krug; Udo Dannlowski Journal: Eur Arch Psychiatry Clin Neurosci Date: 2018-09-28 Impact factor: 5.270
Authors: Katharina Brosch; Frederike Stein; Simon Schmitt; Julia-Katharina Pfarr; Kai G Ringwald; Florian Thomas-Odenthal; Tina Meller; Olaf Steinsträter; Lena Waltemate; Hannah Lemke; Susanne Meinert; Alexandra Winter; Fabian Breuer; Katharina Thiel; Dominik Grotegerd; Tim Hahn; Andreas Jansen; Udo Dannlowski; Axel Krug; Igor Nenadić; Tilo Kircher Journal: Mol Psychiatry Date: 2022-07-15 Impact factor: 13.437
Authors: Harry Rubin-Falcone; Francesca Zanderigo; Binod Thapa-Chhetry; Martin Lan; Jeffrey M Miller; M Elizabeth Sublette; Maria A Oquendo; David J Hellerstein; Patrick J McGrath; Johnathan W Stewart; J John Mann Journal: J Affect Disord Date: 2017-11-13 Impact factor: 4.839
Authors: Frederike Stein; Tina Meller; Katharina Brosch; Simon Schmitt; Kai Ringwald; Julia Katharina Pfarr; Susanne Meinert; Katharina Thiel; Hannah Lemke; Lena Waltemate; Dominik Grotegerd; Nils Opel; Andreas Jansen; Igor Nenadić; Udo Dannlowski; Axel Krug; Tilo Kircher Journal: Schizophr Bull Date: 2021-10-21 Impact factor: 9.306
Authors: Faith M Hanlon; Andrew B Dodd; Josef M Ling; Nicholas A Shaff; David D Stephenson; Juan R Bustillo; Shannon F Stromberg; Denise S Lin; Sephira G Ryman; Andrew R Mayer Journal: Schizophr Res Date: 2021-02-17 Impact factor: 4.939
Authors: Lucas Battel; Fernanda Cunegatto; Anna Viduani; Helen L Fisher; Brandon A Kohrt; Valeria Mondelli; Johnna R Swartz; Christian Kieling Journal: Neuroimage Date: 2021-02-14 Impact factor: 6.556